Corticosteroids clinical pharmacology and therapeutic use

Use of QVAR with a spacer device in children less than 5 years of age is not recommended. In vitro dose characterization studies were performed with QVAR 40 mcg/actuation with the OptiChamber and AeroChamber Plus ® spacer utilizing inspiratory flows representative of children under 5 years old. These studies indicated that the amount of medication delivered through the spacing device decreased rapidly with increasing wait times of 5 to 10 seconds as shown in Table 2. If QVAR is used with a spacer device, it is important to inhale immediately.

Register for alerts
If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Sadeghirad Behnam , Siemieniuk Reed A C , Brignardello-Petersen Romina , Papola Davide , Lytvyn Lyubov , Vandvik Per Olav et al. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials BMJ 2017; 358 :j3887
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    Corticosteroids clinical pharmacology and therapeutic use

    corticosteroids clinical pharmacology and therapeutic use

    Media:

    corticosteroids clinical pharmacology and therapeutic usecorticosteroids clinical pharmacology and therapeutic usecorticosteroids clinical pharmacology and therapeutic usecorticosteroids clinical pharmacology and therapeutic usecorticosteroids clinical pharmacology and therapeutic use

  • http://buy-steroids.org